Specific peptides for the therapeutic targeting of oncogenes., Prive, Gilbert G., and Melnick Ari , Curr Opin Genet Dev, 2006 Feb, Volume 16, Issue 1, p.71-7, (2006)

Reprogramming specific gene expression pathways in B-cell lymphomas., Melnick, Ari , Cell Cycle, 2005 Feb, Volume 4, Issue 2, p.239-41, (2005)

The theoretical basis of transcriptional therapy of cancer: can it be put into practice?, Melnick, Ari M., Adelson Kerin, and Licht Jonathan D. , J Clin Oncol, 2005 Jun 10, Volume 23, Issue 17, p.3957-70, (2005)

ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein., Chevallier, Nathalie, Corcoran Connie M., Lennon Christine, Hyjek Elizabeth, Chadburn Amy, Bardwell Vivian J., Licht Jonathan D., and Melnick Ari , Blood, 2004 Feb 15, Volume 103, Issue 4, p.1454-63, (2004)

The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT., Takahashi, Shinichiro, McConnell Melanie J., Harigae Hideo, Kaku Mitsuo, Sasaki Takeshi, Melnick Ari M., and Licht Jonathan D. , Blood, 2004 Jun 15, Volume 103, Issue 12, p.4650-8, (2004)

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells., Polo, Jose M., Dell'Oso Tania, Ranuncolo Stella Maris, Cerchietti Leandro, Beck David, Da Silva Gustavo F., Prive Gilbert G., Licht Jonathan D., and Melnick Ari , Nat Med, 2004 Dec, Volume 10, Issue 12, p.1329-35, (2004)

Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain., K Ahmad, Farid, Melnick Ari, Lax Stuart, Bouchard Denis, Liu Jun, Kiang Chih-Li, Mayer Sebastian, Takahashi Shinichiro, Licht Jonathan D., and Prive Gilbert G. , Mol Cell, 2003 Dec, Volume 12, Issue 6, p.1551-64, (2003)

Molecular pathogenesis of acute promyelocytic leukaemia and APL variants., Sirulnik, Andres, Melnick Ari, Zelent Arthur, and Licht Jonathan D. , Best Pract Res Clin Haematol, 2003 Sep, Volume 16, Issue 3, p.387-408, (2003)

Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions., Walker, R H., Morgello S, Davidoff-Feldman B, Melnick A, Walsh M J., Shashidharan P, and Brin M F. , Neurology, 2002 Apr 09, Volume 58, Issue 7, p.1031-7, (2002)

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors., Melnick, Ari, Carlile Graeme, K Ahmad Farid, Kiang Chih-Li, Corcoran Connie, Bardwell Vivian, Prive Gilbert G., and Licht Jonathan D. , Mol Cell Biol, 2002 Mar, Volume 22, Issue 6, p.1804-18, (2002)

Histone deacetylases as therapeutic targets in hematologic malignancies., Melnick, Ari, and Licht Jonathan D. , Curr Opin Hematol, 2002 Jul, Volume 9, Issue 4, p.322-32, (2002)

Spotlight on acute promyelocytic leukemia: controversies and challenges., Melnick, A , Leukemia, 2002 Oct, Volume 16, Issue 10, p.1893-5, (2002)

Translocations of the RARalpha gene in acute promyelocytic leukemia., Zelent, A, Guidez F, Melnick A, Waxman S, and Licht J D. , Oncogene, 2001 Oct 29, Volume 20, Issue 49, p.7186-203, (2001)

AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein., Melnick, A, Carlile G W., McConnell M J., Polinger A, Hiebert S W., and Licht J D. , Blood, 2000 Dec 01, Volume 96, Issue 12, p.3939-47, (2000)

The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein., Melnick, A M., Westendorf J J., Polinger A, Carlile G W., Arai S, Ball H J., Lutterbach B, Hiebert S W., and Licht J D. , Mol Cell Biol, 2000 Mar, Volume 20, Issue 6, p.2075-86, (2000)

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions., Melnick, A, Ahmad K F., Arai S, Polinger A, Ball H, Borden K L., Carlile G W., Prive G G., and Licht J D. , Mol Cell Biol, 2000 Sep, Volume 20, Issue 17, p.6550-67, (2000)

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia., Melnick, A, and Licht J D. , Blood, 1999 May 15, Volume 93, Issue 10, p.3167-215, (1999)

Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21., Melnick, A, Fruchtman S, Zelent A, Liu M, Huang Q, Boczkowska B, Calasanz M, Fernandez A, Licht J D., and Najfeld V , Leukemia, 1999 Oct, Volume 13, Issue 10, p.1534-8, (1999)

A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF., Hoatlin, M E., Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, et al. , Blood, 1999 Dec 01, Volume 94, Issue 11, p.3737-47, (1999)

The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase., Ball, H J., Melnick A, Shaknovich R, Kohanski R A., and Licht J D. , Nucleic Acids Res, 1999 Oct 15, Volume 27, Issue 20, p.4106-13, (1999)

Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia., Licht, J D., Shaknovich R, English M A., Melnick A, Li J Y., Reddy J C., Dong S, Chen S J., Zelent A, and Waxman S , Oncogene, 1996 Jan 18, Volume 12, Issue 2, p.323-36, (1996)